110 related articles for article (PubMed ID: 23562632)
41. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
42. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
[TBL] [Abstract][Full Text] [Related]
43. A study on the performance of hyaluronic acid immobilized chitosan film.
Wang Y; Guo L; Ren L; Yin S; Ge J; Gao Q; Luxbacher T; Luo S
Biomed Mater; 2009 Jun; 4(3):035009. PubMed ID: 19498225
[TBL] [Abstract][Full Text] [Related]
44. Controllably local gene delivery mediated by polyelectrolyte multilayer films assembled from gene-loaded nanopolymersomes and hyaluronic acid.
Teng W; Wang Q; Chen Y; Huang H
Int J Nanomedicine; 2014; 9():5013-24. PubMed ID: 25378927
[TBL] [Abstract][Full Text] [Related]
45. Layer-by-layer self-assembly of modified hyaluronic acid/chitosan based on hydrogen bonding.
Manna U; Bharani S; Patil S
Biomacromolecules; 2009 Sep; 10(9):2632-9. PubMed ID: 19694426
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
47. A biocompatible method of controlled retrieval of cell-encapsulating microgels from a culture plate.
Gwon K; Kim M; Tae G
Integr Biol (Camb); 2014 Jun; 6(6):596-602. PubMed ID: 24801132
[TBL] [Abstract][Full Text] [Related]
48. Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering.
Yamane S; Iwasaki N; Majima T; Funakoshi T; Masuko T; Harada K; Minami A; Monde K; Nishimura S
Biomaterials; 2005 Feb; 26(6):611-9. PubMed ID: 15282139
[TBL] [Abstract][Full Text] [Related]
49. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
50. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Varkouhi AK; Verheul RJ; Schiffelers RM; Lammers T; Storm G; Hennink WE
Bioconjug Chem; 2010 Dec; 21(12):2339-46. PubMed ID: 21049986
[TBL] [Abstract][Full Text] [Related]
51. Delivery of siRNA from lyophilized polymeric surfaces.
Andersen MØ; Howard KA; Paludan SR; Besenbacher F; Kjems J
Biomaterials; 2008 Feb; 29(4):506-12. PubMed ID: 17950838
[TBL] [Abstract][Full Text] [Related]
52. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
53. The design of in vitro liver sinusoid mimics using chitosan-hyaluronic acid polyelectrolyte multilayers.
Kim Y; Larkin AL; Davis RM; Rajagopalan P
Tissue Eng Part A; 2010 Sep; 16(9):2731-41. PubMed ID: 20491586
[TBL] [Abstract][Full Text] [Related]
54. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
55. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
56. Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.
Chen M; Gao S; Dong M; Song J; Yang C; Howard KA; Kjems J; Besenbacher F
ACS Nano; 2012 Jun; 6(6):4835-44. PubMed ID: 22621383
[TBL] [Abstract][Full Text] [Related]
57. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
[TBL] [Abstract][Full Text] [Related]
58. Layer-by-layer constructed hyaluronic acid/chitosan multilayers as antifouling and fouling-release coatings.
Yu W; Koc J; Finlay JA; Clarke JL; Clare AS; Rosenhahn A
Biointerphases; 2019 Sep; 14(5):051002. PubMed ID: 31537072
[TBL] [Abstract][Full Text] [Related]
59. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
Lee SH; Chung BH; Park TG; Nam YS; Mok H
Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
[TBL] [Abstract][Full Text] [Related]
60. Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications.
Rujitanaroj PO; Wang YC; Wang J; Chew SY
Biomaterials; 2011 Sep; 32(25):5915-23. PubMed ID: 21596430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
